NCT00589979

Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee

Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 169 (actual)
• Sponsor: Endo Pharmaceuticals · Industry
• Sex: All
• Age: 37 Years
• Healthy volunteers: Not accepted

Summary

Patients with knee pain due to Osteoarthritis (OA) experiencing sub-optimal pain relief from their current analgesic regimen will participate in a pilot clinical trial to evaluate the effectiveness and tolerability of the Lidoderm Patch compared with placebo in treating knee pain from OA.

Conditions

• Osteoarthritis of the Knee

Interventions

Type	Name	Description
DRUG	Lidoderm (Lidocaine 5% Patch)	Topical Patch
DRUG	Placebo Patch	Topical Patch

Timeline

• Start date: 2007-03-01
• Primary completion: 2008-06-01
• Completion: 2008-10-01
• First posted: 2008-01-10
• Last updated: 2017-10-05
• Results posted: 2010-09-22

Locations

20 sites across 1 country: United States